Fulei Liu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Nanoplatforms for cancer theranostics 16
-
- Natural product bioactivities and synthesis 3
- Co-authors
- Wenyuan Liu (22 shared papers)Feng Feng (19 shared papers)Wei Qu (17 shared papers)Renjie Luo (6 shared papers)Jingwei Xue (16 shared papers)Xiaoxian Huang (15 shared papers)Lingfei Han (12 shared papers)Mangmang Sang (6 shared papers)
In The Last Decade
Fulei Liu
34 papers receiving 868 citations
Peers
Comparison fields: 5 of 81
- Biomaterials 202
- Cancer Research 130
- Biomedical Engineering 403
- Pulmonary and Respiratory Medicine 242
- Pharmaceutical Science 42
Countries citing papers authored by Fulei Liu
This map shows the geographic impact of Fulei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulei Liu more than expected).
Fields of papers citing papers by Fulei Liu
This network shows the impact of papers produced by Fulei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulei Liu. The network helps show where Fulei Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fulei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 138 | |
| 2 | 2020 | 90 | |
| 3 | 2020 | 63 | |
| 4 | 2019 | 61 | |
| 5 | 2020 | 58 | |
| 6 | 2019 | 44 | |
| 7 | 2021 | 40 | |
| 8 | 2018 | 38 | |
| 9 | 2024 | 33 | |
| 10 | 2021 | 32 | |
| 11 | 2022 | 29 | |
| 12 | 2021 | 24 | |
| 13 | Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma. | 2014 | 23 |
| 14 | 2020 | 21 | |
| 15 | 2018 | 20 | |
| 16 | 2014 | 20 | |
| 17 | 2018 | 20 | |
| 18 | 2019 | 18 | |
| 19 | 2017 | 14 | |
| 20 | 2022 | 12 |
About Fulei Liu
Fulei Liu is a scholar working on Biomedical Engineering, Molecular Biology, Pulmonary and Respiratory Medicine, Plant Science and Biomaterials, having authored 36 papers that have together received 875 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (16 papers), Photodynamic Therapy Research Studies (7 papers), Nanoparticle-Based Drug Delivery (5 papers), Natural Compound Pharmacology Studies (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Carbohydrate Chemistry and Synthesis (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Biomaterials (202 citations), Cancer Research (130 citations), Biomedical Engineering (403 citations), Pulmonary and Respiratory Medicine (242 citations) and Pharmaceutical Science (42 citations). Fulei Liu has collaborated with scholars based in China, Thailand and Japan. Frequent co-authors include Wenyuan Liu, Feng Feng, Wei Qu, Renjie Luo, Jingwei Xue, Xiaoxian Huang, Lingfei Han, Mangmang Sang, Ruyi Wang and Jun Dou. Their work appears in journals such as Biomaterials Science, Journal of Biomedical Nanotechnology, Analytical Chemistry, Chemical Engineering Journal and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.